All Pharma News
price-trendAsk Us
Immusoft To Present on ISP-001 Clinical Trial at WORLDSymposium™ 2024 Conference

Immusoft To Present on ISP-001 Clinical Trial at WORLDSymposium™ 2024 Conference
BUSINESSWIRE
03 Jan 2024
Share Share
Immusoft Administers the First Engineered B Cell in a Human Clinical Trial

Immusoft Administers the First Engineered B Cell in a Human Clinical Trial
BUSINESSWIRE
15 Dec 2023
Share Share
In a first, Immusoft gives engineered B cell in a clinical trial

In a first, Immusoft gives engineered B cell in a clinical trial
Nick Paul Taylor FIERCE BIOTECH
15 Dec 2023
Share Share
Immusoft Acquires Rights to Property for Genome Edited Primary B Cells

Immusoft Acquires Rights to Property for Genome Edited Primary B Cells
BUSINESSWIRE
27 Mar 2023
Share Share
Immusoft Awarded $8M in Funding from the CIRM for MPS I Clinical Program

Immusoft Awarded $8M in Funding from the CIRM for MPS I Clinical Program
BUSINESSWIRE
27 Jan 2023
Share Share
Immusoft Announces FDA Clearance of IND Application for ISP-001 for MPS I

Immusoft Announces FDA Clearance of IND Application for ISP-001 for MPS I
BUSINESSWIRE
01 Sep 2022
Share Share
Immusoft and Takeda to develop cell therapies for rare metabolic disorders

Immusoft and Takeda to develop cell therapies for rare metabolic disorders
PHARMACEUTICAL-TECHNOLOGY
14 Oct 2021
Share Share
Takeda inks another biobucks pact: $900M for Immusoft`s B cells

Takeda inks another biobucks pact: $900M for Immusoft`s B cells
Kyle LaHucik FIERCEBIOTECH
14 Oct 2021
Share Share
Immusoft Announces Formation of Scientific Advisory Board

Immusoft Announces Formation of Scientific Advisory Board
BUSINESSWIRE
23 Jun 2021
Share Share